Acute cocaine treatment enhances the antagonistic allosteric adenosine A2A-dopamine D2 receptor-receptor interactions in rat dorsal striatum without increasing significantly extracellular dopamine levels. 2020

Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala, Sweden.

BACKGROUND Antagonistic adenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) receptor-receptor interactions have previously been demonstrated in A2AR-D2R heteroreceptor complexes in the rat dorsal striatum. They mainly involve a reduction of affinity in the high-affinity component of the D2R agonist binding site upon activation in vivo of the A2AR by an A2AR agonist. Upon cocaine self-administration, this antagonistic A2AR-D2R interaction disappeared in the dorsal striatum. METHODS In the current experiments, it was tested whether such modifications in the antagonistic A2AR-D2R receptor-receptor interactions can develop also after an acute systemic injection of a low cocaine dose (1 mg/kg; sc). RESULTS Microdialysis experiments indicated that acute cocaine did not significantly alter the extracellular dopamine levels in the dorsal striatum of the awake Wistar rats. Competition dopamine receptor binding experiments demonstrated that in the acute cocaine group, the A2AR agonist CGS-21680 produced significantly larger increases in the D2R Ki, High values (reduction of high-affinity) versus the saline-injected (i.e. control) group. Furthermore, in the dorsal striatum membrane preparation from acute cocaine-injected rats, CGS-21680 also produced significant increases in the D2R Ki, Low values (reduction of low-affinity) and in the proportion of D2Rs in the high-affinity state (RH). Such significant effects were not observed with CGS-21680 in the control group. CONCLUSIONS The molecular mechanism involved in the acute cocaine-induced increase in the antagonistic allosteric A2AR-D2R receptor-receptor interactions may be an increased formation of higher-order complexes A2AR-D2R-sigma1R in which cocaine by binding to the sigma1R protomer also allosterically enhances the inhibitory A2AR-D2R interaction in this receptor complex.

UI MeSH Term Description Entries
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D000495 Allosteric Site A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties. Allosteric Sites,Site, Allosteric,Sites, Allosteric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
May 2016, Neuropharmacology,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
May 2016, Pharmacology, biochemistry, and behavior,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
July 2015, Proceedings of the National Academy of Sciences of the United States of America,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
December 2017, Cellular signalling,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
November 2000, The European journal of neuroscience,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
January 1996, European journal of pharmacology,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
December 1995, European journal of pharmacology,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
October 2009, The Journal of biological chemistry,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
August 2011, BioTechniques,
Wilber Romero-Fernandez, and Zilong Zhou, and Sarah Beggiato, and Karolina Wydra, and Malgorzata Filip, and Sergio Tanganelli, and Dasiel O Borroto-Escuela, and Luca Ferraro, and Kjell Fuxe
November 1994, Biochemical pharmacology,
Copied contents to your clipboard!